Screening organometallic thiophene containing thiosemicarbazone ruthenium (II/III) complexes as potential anti-tumour agents
- 22 March 2018
- journal article
- research article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 23 (3) , 425-435
Abstract
The new ruthenium (III) complex has been synthesized and characterized by elemental analysis, FT-IR, UV–Vis, EI-Mass, EPR spectroscopy, and magnetic susceptibility measurement. Cytotoxic effects of organoruthenium (II/III) complexes 1a, 1b, and 2a, and their ligands (TSC1 and TSC2) in cultured human ovarian (A2780, SKOV-3, and OVCAR-3) and colon (DLD, CCD18Co, and Caco-2) cells have been investigated comparing reactivity of the Ru (II/III) complexes and their free TSC ligands. The complexes exhibit higher cytotoxicity in three cancer cell lines than in normal cells. The binding with CT-DNA and BSA of the all complexes were weak compared with their ligand in spite of the cellular uptake of these complexes into the cytoplasm and then nucleus while their cytotoxic effects were vice versa. All the results showed that Complex 1b has more efficient cytotoxicity on the colon cancer cells than ovarian cancer cells. However, Complex 2a is a better drug candidate especially for antitumor therapy of metastasized ovarian cancer.Keywords
Funding Information
- The Scientific and Technological Research Council of Turkey (215Z663)
This publication has 67 references indexed in Scilit:
- Mixed ligand ruthenium(III) complexes of benzaldehyde 4-methyl-3-thiosemicarbazones with triphenylphosphine/triphenylarsine co-ligands: Synthesis, DNA binding, DNA cleavage, antioxidative and cytotoxic activityJournal of Molecular Structure, 2013
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Ferrocenoyl Pyridine Arene Ruthenium Complexes with Anticancer Properties: Synthesis, Structure, Electrochemistry, and CytotoxicityInorganic Chemistry, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Ruthenium(III) Complexes with a Phenolate‐O, Imine‐N, and Amide‐O Coordinating Ligand: Syntheses, Structures, Properties, and Protonation Studies of Coordinated AmideEuropean Journal of Inorganic Chemistry, 2003
- Binding of Antitumor Ruthenium(III) Complexes to Plasma ProteinsMetal-Based Drugs, 2000
- Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cellsEuropean Journal of Cancer, 1997
- A FACILE SYNTHESIS OF THIOSEMICARBAZIDESAND THIOSEMICARBAZONES BY THETRANSAMINATION OF 4-METHYL-4-PHENYL-3-THIOSEMICARBAZIDEPhosphorus, Sulfur, and Silicon and the Related Elements, 1991
- Synthesis, characterization, and EPR studies of stable ruthenium(III) Schiff base chloro and carbonyl complexesInorganic Chemistry, 1990
- Mixed complexes of ruthenium(III) and ruthenium(II) with triphenylphosphine or triphenylarsine and other ligandsJournal of Inorganic and Nuclear Chemistry, 1977